NPM1 and acute myeloid leukemia: In a more recent study, approximately 1000 miRs were sequenced from AML samples and compared to peripheral blood samples collected from control subjects which revealed a higher number of aberrantly expressed miRs in NPM1-mutated and FLT3-mutated AML patients compared to control subjects (50).